Neuracle Neuroscience

Neuracle Neuroscience is a Beijing-based neurotechnology company specializing in the development of wireless electroencephalography (EEG) systems and brain-computer interface (BCI) platforms for both clinical and consumer applications. The company's flagship product line, the NeuSen W series, represents its core hardware offering — a range of wireless EEG headsets engineered to deliver high-fidelity neural signal acquisition without the constraints of traditional wired systems. These devices are designed to meet the rigorous demands of hospital environments and research settings, combining portability with clinical-grade signal quality. Neuracle's technology stack extends beyond hardware, incorporating software platforms and BCI frameworks that enable real-time neural data processing and interpretation across a variety of use cases.

Neuracle Neuroscience has established a meaningful commercial footprint across Asia, with its NeuSen W series deployed in hospitals and research institutions throughout the region. The company has secured Series B funding totaling $15 million, reflecting growing investor confidence in its technology roadmap and market traction. This capital positions Neuracle to accelerate product development, expand its clinical partnerships, and pursue broader regulatory clearances in key markets. The company's growing presence in Asian healthcare and research ecosystems highlights its ability to translate laboratory-grade neuroscience tools into practical, scalable clinical solutions.

Neuracle Neuroscience represents an important voice in the global neurodiagnostics landscape, particularly as the field shifts toward wireless, ambulatory, and patient-friendly neural monitoring solutions. By advancing accessible BCI and EEG technology within a high-growth Asian market, the company is helping to democratize neurotechnology beyond the traditionally Western-dominated centers of innovation. Their work contributes to a broader industry movement toward decentralized neurological assessment, with implications for epilepsy monitoring, cognitive research, and emerging BCI-driven therapies. As clinical demand for portable neurodiagnostic tools continues to rise, companies like Neuracle are well-positioned to shape the next generation of brain monitoring infrastructure.